Endocrinol Metab.  2014 Sep;29(3):248-250. 10.3803/EnM.2014.29.3.248.

Cost-of-Illness Trend of Thyroid Gland Disease in Korea

• Chung JH

• KMID: 2169460
• DOI: http://doi.org/10.3803/EnM.2014.29.3.248

Abstract

No abstract available.

MeSH Terms

Korea
Thyroid Gland*

Reference

1. Ministry of Health and Welfare. Korea Cancer Registry Statics in 2011 [Internet]. Sejong: Ministry of Health and Welfare;2014. updated 2013 Dec 26. cited 2014 Jul 23. Available from: http://www.mw.go.kr/front_new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=294942&page=1.

2. Chung JH. A refutation against unfounded reports on thyroid cancer. J Korean Thyroid Assoc. 2014; 7:1–6.

3. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics,1980-2005. Cancer Epidemiol Biomarkers Prev. 2009; 18:784–791.

4. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002; 99:260–266.

5. Mousavi SM, Brandt A, Sundquist J, Hemminki K. Risks of papillary and follicular thyroid cancer among immigrants to Sweden. Int J Cancer. 2011; 129:2248–2255.

6. Park YJ, Ahn HY, Choi HS, Kim KW, Park do J, Cho BY. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid. 2012; 22:356–362.

7. Seo GH, Kim SW, Chung JH. Incidence & prevalence of hyperthyroidism and preference for therapeutic modalities in Korea. J Korean Thyroid Assoc. 2013; 6:56–63.

8. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001; 22:91–113.

9. Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ. 2008; 17:947–959.

10. Woodward RM, Brown ML, Stewart ST, Cronin KA, Cutler DM. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer. 2007; 110:2511–2518.

11. Hyun KR, Kang S, Lee S. Cost-of-illness trends associated with thyroid disease in Korea. Endocrinol Metab. 2014; 29:257–269.

12. Jung YH, Ko S. The socioeconomic cost of diseases in Korea. J Prev Med Public Health. 2006; 39:499–504.

13. Jung YH. Cost of illness and health-friendly fiscal policy. Health Welf Policy Forum. 2010; 156:50–61.

14. Shin JY, Kim SY, Lee KS, Lee SI, Ko Y, Choi YS, Seo HG, Lee JH, Park JH. Costs during the first five years following cancer diagnosis in Korea. Asian Pac J Cancer Prev. 2012; 13:3767–3772.

15. Brown RL, de Souza JA, Cohen EE. Thyroid cancer: burden of illness and management of disease. J Cancer. 2011; 2:193–199.